Drug Shortage Report for FLUMAZENIL INJECTION
Report ID | 144794 |
Drug Identification Number | 02266342 |
Brand name | FLUMAZENIL INJECTION |
Common or Proper name | Flumazenil Injection 0.1 mg/mL MD Vial 5 mL |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | FLUMAZENIL |
Strength(s) | 0.1MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 5 mL |
ATC code | V03AB |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2021-09-01 |
Actual start date | |
Estimated end date | 2021-11-03 |
Actual end date | 2021-11-03 |
Shortage status | Resolved |
Updated date | 2021-11-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2021-11-04 | English | Compare |
v7 | 2021-11-03 | French | Compare |
v6 | 2021-11-03 | English | Compare |
v5 | 2021-10-12 | French | Compare |
v4 | 2021-10-12 | English | Compare |
v3 | 2021-09-02 | English | Compare |
v2 | 2021-08-27 | French | Compare |
v1 | 2021-08-27 | English | Compare |
Showing 1 to 8 of 8